Evidence map›Paper›PMID 40927981›Full record

ReviewEndocrine reviews2026

Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases.

S R Murthy Madiraju, Elite Possik, Fahd Al-Mulla, Christopher J Nolan, Marc Prentki

Abstract readReview
In one paragraph

Review in Endocrine reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. International journal of molecular sciences · 2026
    Article
  5. "Alternative" or integrated role of mitochondrial glycerol-3-phosphate dehydrogenase.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. When alternative becomes essential: The role of mitochondrial glycerol-3-phosphate dehydrogenase.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

S R Murthy MadirajuDepartment of Nutrition, Biochemistry and Molecular Medicine, University of Montreal, Montreal, QC, Canada H2X 0A9.ORCID 0000-0002-2613-2074
Elite PossikDREAM-CV Lab, Research Institute of the McGill University Health Center (RI-MUHC), Montreal, QC, Canada H4A 3S5.
Fahd Al-MullaTranslational Research Department, Dasman Diabetes Institute, Kuwait City 15462, Kuwait.ORCID 0000-0001-5409-3829
Christopher J NolanSchool of Medicine and Psychology and John Curtin School of Medical Research, College of Health and Medicine, Australian National University, the Canberra Hospital, Canberra, ACT 2605, Australia.
Marc PrentkiDepartment of Nutrition, Biochemistry and Molecular Medicine, University of Montreal, Montreal, QC, Canada H2X 0A9.ORCID 0000-0002-0499-3324

Funding

Canadian Institute of Health ResearchDasman Diabetes Institutethe Hevolution Foundation
6 · The paper itself

Abstract

Glycerol and glycerol-3-phosphate (Gro3P) are key metabolites at the intersection of carbohydrate, lipid, and energy metabolism. Their production and usage are organismal and cell-type specific. Glycerol has unique physicochemical properties enabling it to function as an osmolyte, protein structure stabilizer, and an antimicrobial and antifreeze agent, important to the preservation of many biological functions. Glycerol and Gro3P are implicated in many physiological and disease processes relating to energy metabolism, thermoregulation, hydration, skin health, male fertility, aging, and cancer. Glycerol has countless applications in the food, pharmaceutical, and cosmetics industries. It is used as a sweetener, preservative, thickening agent, humectant, osmolyte, and cryoprotectant. It is widely used in skin and wound care products, laxatives, in cell and tissue preservation, and in medicines for numerous conditions. Here, we review the multiple uses and functions of glycerol and Gro3P and associated transporters, enzymes, and target genes in health, senescence, and disease. We discuss the evidence that glycerol may be present at much higher levels in tissues and cells than in the blood. We bring particular focus to the newly identified glycerol shunt in the direct formation of glycerol independent of lipolysis and as a pathway allowing cells to adapt to various stresses. Relevant to chronic metabolic diseases, cancer and aging, glycerol and Gro3P present important translational implications and thus warrant much more attention.

Indexed as

GlycerolGlycerophosphatesNeoplasmsAnimalsEnergy MetabolismHumansalpha-glycerophosphoric acidGlycerolGlycerophosphatesenergy metabolismglycerol-3-phosphateglycerolipid cycleglycerol metabolismglycerol shuntglyceroneogenesis

Identifiers

PMID40927981
PMCPMC12795705

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.